Collaborative normal tension glaucoma study

Current Opinion in Ophthalmology

Volumn 14, Issue 2, 2003, Pages 86-90

  Anderson, Douglas R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Natural course of untreated glaucoma; Normal tension glaucoma; Risk factors for glaucoma

Indexed keywords

ANTIGLAUCOMA AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTICENTER STUDY; NORMAL TENSION GLAUCOMA; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TRABECULOPLASTY;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; VISUAL FIELDS;

EID: 0037564124     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200304000-00006     Document Type: Review

References (11)

1. Anderson, DR: Normal Tension Glaucoma study. Clinical Trials in Ophthalmology: A Summary and Practice Guide. Edited by Kertes PJ, Conway MD. Baltimore: Williams & Wilkins, 1997:335-348.
2. Schulzer M and the Normal Tension Study Glaucoma Group. Intraocular pressure reduction in normal tension glaucoma patients. Ophthalmology 1992, 99:1468-1470.
3. Schulzer M and the Normal-tension Glaucoma Study Group. Errors in the diagnosis of visual field progression in normal tension glaucoma. Ophthalmology 1994, 101:1589-1595.
4. Collaborative Normal-tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998, 126:487-497.
5. Collaborative Normal-tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998, 126:498-505.
6. Anderson DR, Drance SM, Schulzer M: Replies to correspondence to the editor. Am J Ophthalmol 1999, 127:624-626.
7. Drance SM, Anderson DR, Schulzer M: Replies to correspondence to the editor. American Journal of Ophthalmology 1999, 128:776-777.
8. Anderson DR, Drance SM, and Schulzer, M, writing committee for the Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal tension glaucoma. Ophthalmology 2001, 108:247-253. Rate of progression in untreated cases is highly variable, and half the patients diagnosed with normal tension glaucoma did not have detected field deterioration in 5 years.
9. Anderson DR, Drance SM: Reply to letter re: Normal-tension glaucoma history. Ophthalmology 2002, 109:3.
10. Anderson DR, Drance SM: Not quite natural history of NTG. [letter]. Ophthalmology 2002, 109:1041-1042.
11. Anderson DR, Drance SM, and Schulzer, M, writing committee for the Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal tension glaucoma. Am J Ophthalmol 2001, 131:699-708. Migrain, female sex, and presence of disc hemorrhage at time of diagnosis were the prime predictors of risk of faster disease progression without treatment.